Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alcoholic Hepatitis.

Kaushik Agarwal1, Nickolas Kontorinis, Nickolas Kontorinis

  • 1Department of Medicine, Mount Sinai Medical Center, One Gustave Levy Place, New York, NY 10029-6574, USA.

Current Treatment Options in Gastroenterology
|November 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incident Hypertension with Antiretroviral Therapy in the OPERA Cohort.

Journal of the International Association of Providers of AIDS Care·2026
Same author

A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for the Switch to Two-Drug Antiretroviral Regimens in People With HIV.

Open forum infectious diseases·2025
Same author

Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis B.

AIDS (London, England)·2025
Same author

Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real-world evidence from the OPERA cohort.

HIV medicine·2025
Same author

Novel Implementation of Hepatitis B to Hepatitis Delta Reflex Testing in a US Healthcare System.

The American journal of gastroenterology·2025
Same author

Translating Hepatitis D Virus Screening Cost-Effectiveness into Practice: The Case for Reflex Testing in the United States.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Alcoholic hepatitis (AH) is a severe liver condition. While corticosteroids are controversial, they may help selected patients, and new targeted therapies show promise for managing this alcohol-related liver disease.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Alcoholic hepatitis (AH) is a prevalent liver disease linked to substantial illness and death.
  • Diagnosis often involves a history of heavy alcohol use and signs of liver decompensation.
  • AH is histologically defined as acute hepatic inflammation due to alcohol exposure.

Purpose of the Study:

  • To review current understanding and treatment of alcoholic hepatitis.
  • To discuss the role of corticosteroids and emerging targeted therapies.
  • To clarify management strategies based on disease severity.

Main Methods:

  • Review of existing literature on alcoholic hepatitis pathogenesis and treatment.
  • Analysis of therapeutic interventions, particularly for severe AH.

Related Experiment Videos

  • Assessment of diagnostic criteria and prognostic indicators like the Maddrey score.

    • Main Results:

    • Corticosteroids, though debated, are recommended for specific AH patients.
    • Emerging therapies targeting disease pathogenesis, including anti-TNF-α monoclonals and pentoxifylline, are under investigation.
    • The Maddrey score is crucial for determining prognosis and guiding treatment decisions.

    Conclusions:

    • Long-term alcohol abstinence, nutrition, and lifestyle changes are primary treatment goals.
    • Corticosteroids remain a treatment option for selected severe AH cases.
    • Orthotopic liver transplantation is generally not advised for severe AH patients with uncertain long-term alcohol abstinence.